Sand Cosmetic Inc

Preventive Medicine, Public Health & General Preventive Medicine in Los Angeles, California — the CMS registry also lists obesity medicine among its taxonomies.

Practice Details

Address
1964 Westwood Blvd
Los Angeles, CA 90025
Geocoded location: 34.0472, -118.4346
Taxonomy
Family Medicine, Bariatric Medicine
NPPES Enumeration
Listed with NPPES since 2013
Registered Contact
NANCY SAND, PRESIDENT
NPPES Record Updated
December 2013

Specialty taxonomies on file (2)

  • Bariatric Surgery
    Family Medicine, Obesity Medicine
  • Preventive Medicine, Public Health & General Preventive Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Practice

Sand Cosmetic Inc is enumerated with NPPES as a Preventive Medicine, Public Health & General Preventive Medicine clinic; the CMS registry also lists obesity medicine among its taxonomies. The registry does not break out which specialties are staffed at this location — call ahead to confirm obesity-medicine or GLP-1 services are actively offered here.

This practice address has 1 individual clinician enumerated with NPPES under the same location.

Sand Cosmetic Inc, on the NPI registry since 2013, is the only listing on the Los Angeles clinic list with Preventive Medicine, Public Health & General Preventive Medicine as its specialty on file; the other 282 are listed under 16 other specialties. Medicaid in California ended its weight-loss coverage of GLP-1s, though it covers Wegovy for heart-attack and stroke risk, Zepbound for sleep apnea and Wegovy for MASH liver disease with prior authorization; our California Medicaid GLP-1 coverage guide has the current criteria and the appeal process. Telehealth programs licensed in California start at $87/mo for compounded semaglutide and $119/mo for compounded tirzepatide; they are compared on our Los Angeles GLP-1 telehealth page and, statewide, the California GLP-1 provider page, and the national field is in our cheapest compounded semaglutide list.

GLP-1 access in Los Angeles, California

Adult obesity rate
28.1%
#44 of 50 states (CDC BRFSS)
Median compounded semaglutide
$175/mo
Ongoing month-to-month telehealth price in California
Medicaid GLP-1 coverage
Diabetes only
California Medicaid, obesity indication

About 28.1% of California adults have obesity (BMI 30+), ranking the state #44 of 50 (CDC BRFSS). Our directory currently lists 283 GLP-1-relevant clinics in Los Angeles. If a cash-pay route makes more sense, the median ongoing price for compounded semaglutide from telehealth providers serving California is $175/mo, well below brand-name Wegovy or Zepbound list prices.

Explore more California options on the best California GLP-1 providers page, browse every Los Angeles listing in the Los Angeles clinic directory. Nearby towns with their own clinic lists include West Hollywood, Beverly Hills, and Culver City.

Nearby Practices

The closest similar listings in our directory are Oband Medical Group, Inc. (bariatric surgery, under a mile away), UC Regents UCLA Medical Center (internal medicine, about 1 mile away), and The Regents of the University of California (internal medicine, about 1 mile away). Distances are straight-line from the addresses on file with the NPI registry.

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to California addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured California telehealth partners:

Featured Partners · Los Angeles

Featured GLP-1 providers serving Los Angeles

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

  1. Top pick
    7.7

    Compounded from

    See pricing

    Get started →
  2. Compounded from

    $79/mo

    “starting at” price

    Get started →
  3. Compounded from

    $79/mo

    sale price

    Get started →
  4. 8.2

    Compounded from

    $129/mo

    starting dose

    Get started →
  5. Compounded from

    $169/mo

    12-month plan rate

    Get started →
  6. 8.1

    Compounded from

    $200/mo

    starting dose

    Get started →

See more Los Angeles options on the Los Angeles clinic directory, our Los Angeles GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Los Angeles obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Sand Cosmetic Inc's specialty taxonomy but not the specific medications it prescribes or its current service menu. Sand Cosmetic Inc is listed under Preventive Medicine, Public Health & General Preventive Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 310-441-2263 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Sand Cosmetic Inc's primary specialty on file is Preventive Medicine, Public Health & General Preventive Medicine, and the registry also lists obesity medicine among its taxonomies. The registry records the taxonomy on file, not the individual clinicians staffed at this location.
Sand Cosmetic Inc is located at 1964 Westwood Blvd, Los Angeles, CA 90025. The phone number listed in the registry is 310-441-2263. Its full record is public in the CMS National Provider registry under NPI 1043641152.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Sand Cosmetic Inc is currently accepting new patients. Call the practice at 310-441-2263 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.